Moldova latest patents query
The latest invention patents collect the data information of Moldova invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Set of elements for installing photovoltaic panels by manually positioning a tab-type clamp
PendingMDE20260351A1
Owner:PEREZ LOPEZ BENITO
Methods for quantifying drug concentration in a prodrug composition
PendingMDE20260386A1
Owner:GENZYME CORP
Pharmaceutical compositions comprising a PKC inhibitor
PendingMDE20260514A1
Owner:IDEAYA BIOSCIENCES INC
Amido pyrido[3,4-b]indole-1, 4-dione compounds for treatment of porphyrias
PendingMDE20260217A1
Owner:PORTAL THERAPEUTICS INC
Spray-dried compositions comprising adrenergic receptor modulators
PendingMDE20260286A1
Owner:OREXO AB
Treatment methods for subjects with non-small cell lung cancer having an aberration in EGFR
PendingMDE20260370A1
Owner:TAIHO PHARMA CO LTD
Method for the production of multilaminar wood sheets that reproduces the grain of natural wood essences
PendingMDE20260061A1
Owner:ALPI SRL
Substituted indazole propionic acid derivative compounds and uses thereof as AMPK activators
PendingMDE20260119A1
Owner:PFIZER INC
Combinations comprising BCR:ABL-1 inhibitor and a second tyrosine kinase inhibitor for use in the treatment of cancer
PendingMDE20260534A1
Owner:TERNS PHARMACEUTICALS INC
Dose detection and drug identification for a medication delivery device
PendingMDE20260579A1
Owner:ELI LILLY & CO
Methods of preparing compounds for treating pain and solid forms thereof
PendingMDE20260692A1
Owner:VERTEX PHARMACEUTICALS INC
Dosing strategy that mitigates cytokine release syndrome for CD3 / CD20 bispecific antibodies
PendingMDE20260354A1
Owner:REGENERON PHARMACEUTICALS INC
Calcitonin analogue, and derivative thereof and use thereof
PendingMDE20260142A1
Owner:HANG ZHOU SCIWIND BIOSCIENCES CO LTD +1
Substituted cyclic compounds and methods of treating phenylketonuria and other amino acidurias
PendingMDE20260362A1
Owner:SANOFI SA(FR)
Knitted micromassaging compression garment for the breast region
PendingMDE20260552A1
Owner:CALZIFICIO PINELLI
Compositions and methods for tank-mix spray application of 1-MCP
PendingMDE20260092A1
Owner:AGROFRESH INC
Compounds and pharmaceutical compositions that degrade SWI / SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A
PendingMDE20260326A1
Owner:PLEXIUM INC
Compositions and methods of using PLN-targeting antibody-oligonucleotide conjugates
PendingMDE20260371A1
Owner:ATRIUM THERAPEUTICS INC
Administration of fibronectin based scaffold domain proteins to treat overweight, obesity, and related health conditions
PendingMDE20250953A1
Owner:BIOHAVEN THERAPEUTICS LTD
A smart insect trap and a method for using such a smart insect trap
PendingMDE20260550A1
Owner:STRYGOO BV +1
Reverse transcription-mediated gene editing systems and uses thereof
PendingMDE20260533A1
Owner:ARBOR BIOTECHNOLOGIES INC
Macrocyclic compounds and use as TYK2 inhibitors
PendingMDE20260383A1
Owner:BLOSSOMHILL THERAPEUTICS INC
Feedstocks and methods for fabrication of iron electrodes using sulfide-containing particles
PendingMDE20250946A1
Owner:FORM ENERGY INC
Dual payload antibody drug conjugates for the treatment of cancer
PendingMDE20260051A1
Owner:ARARIS BIOTECH AG
Combination comprising a KRAS G12D inhibitor and an EGFR inhibitor for use in the treatment of cancer
PendingMDE20260644A1
Owner:INCYTE CORP
Nanoemulsion adjuvant compositions for human papillomavirus vaccines
PendingMDE20260309A1
Owner:MERCK SHARP & DOHME LLC
Means and methods for diagnosing cancer and / or an acute inflammatory disease
PendingMDE20260043A1
Owner:CARCIMUN BIOTECH GMBH
Non-human animals having an engineered immunoglobulin lambda light chain locus
PendingMDE20260298A1
Owner:REGENERON PHARMACEUTICALS INC
Antibody-drug conjugates based on molecular glue degraders and uses thereof
PendingMDE20260500A1
Owner:MABLINK BIOSCIENCE SAS +7
Products and methods for inducing immune responses to bacteria
PendingMDE20260554A1
Owner:IMMUNETHEP SA
Compounds and methods for modulating alpha-synuclein expression
PendingMDE20260016A1
Owner:IONIS PHARMACEUTICALS INC
Vaporizing unit comprising a ceramic and electronic cigarette with removable cartridge incorporating such a vaporizing unit
PendingMDE20260114A1
Owner:PARNASSE 26 HOLDING
Ascorbic acid and ferrous iron compositions with adipocyte-lowering effect
PendingMDE20260046A1
Owner:FARMACIA METALLA SRL
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
PendingMDE20260096A1
Owner:VERTEX PHARMACEUTICALS INC
Compounds and compositions as VHL ligands and STAT3 degraders and uses thereof
PendingMDE20260341A1
Owner:THE RGT UNIV OF MICHIGAN
A triple reuptake inhibitor for use in methods of treating a behavioral immuno-metabolic cluster condition or disorder
PendingMDE20260526A1
Owner:NOEMA PHARMA AG
Reverse transcription-mediated gene editing systems and uses thereof
PendingMDE20260556A1
Owner:ARBOR BIOTECHNOLOGIES INC
MHC class I chain-related protein A (MICA)-specific antibodies and uses thereof
PendingMDE20260324A1
Owner:AAKHA BIOLOGICS INC
Anti-TROP2 antibody-drug conjugates comprising PNU-159682 derivatives
PendingMDE20260214A1
Owner:MERCK SHARP & DOHME LLC
Nucleic acid regulation of MSH3 in repeat expansion disorders
PendingMDE20260639A1
Owner:UNIQURE BIOPHARMA BV
Formulations comprising ActRIIa polypeptide variants
PendingMDE20260076A1
Owner:MERCK SHARP & DOHME LLC
Delivery and measurement of fluorescent nanocrystals in biological tissue
PendingMDE20260283A1
Owner:UNIVERSITY OF GRONINGEN +1
Pharmaceutical compositions comprising antibodies binding to CD30 and CD3
PendingMDE20260122A1
Owner:GENMAB AS
New cutout for elastic aligners, method of manufacturing same and system for orthodontic treatment
PendingMDE20260617A1
Owner:UAB ORDOLINE
Substituted tricyclic compounds as KRAS degraders
PendingMDE20260650A1
Owner:AURIGENE ONCOLOGY LIMITED
Sacrificial element for the production of ribbed bodies of composite material
PendingMDE20260088A1
Owner:ADDYX SRL
Methods for treating multiple myeloma comprising an anti-CD38 antibody combined with bortezomib, lenalidomide and dexamethasone
PendingMDE20260647A1
Owner:JANSSEN BIOTECH INC
Allele-selective compounds and methods for modulating huntingtin expression
PendingMDE20260018A1
Owner:IONIS PHARMACEUTICALS INC
Combination of IAP inhibitors and cellular kinase inhibitors, such as ponatinib, for use in the treatment of cancer or pulmonary diseases, such as COPD, cystic fibrosis, pulmonary fibrosis and COVID-19
PendingMDE20260693A1
Owner:UNIV HOUSTON SYST +1
Modified-release granulate of active ingredients and / or nutritional ingredients and methods of making
PendingMDE20260624A1
Owner:S I I T SRL SERVIZIO INTERNAZIONALE IMBALLAGGI TERMOSALDANTI IT
Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form
PendingMDE20260430A1
Owner:EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENY TARSASAG
DPP1 inhibitor intermediate, and preparation method therefor and use thereof in medicines
PendingMDE20260367A1
Owner:HAISCO PHARM PTE LTD
Subcutaneous formulations of Anti-cd38 antibodies and their uses
PendingMDE20250939A1
Owner:JANSSEN BIOTECH INC
Compounds and pharmaceutical compositions thereof for the treatment of diseases
PendingMDE20260598A1
Owner:COULTREON BIOPHARMA BV
Uplink sounding reference signal transmission mechanism
PendingMDE20260006A1
Owner:NOKIA TECHNOLOGIES OY
Modulators of cystic fibrosis transmembrane conductance regulator
PendingMDE20260622A1
Owner:VERTEX PHARMACEUTICALS INC
High-strength metal grid for containment and protection and machine for the production thereof
PendingMDE20260069A1
Owner:OFFICINE MACCAFERRI SPA
Compounds and methods for reducing ATN1 expression
PendingMDE20260515A1
Owner:IONIS PHARMACEUTICALS INC
Agglomerated crystalline medium chain fatty acid salts
PendingMDE20260700A1
Owner:MERCK SHARP & DOHME LLC
Compositions and methods for an antibody drug conjugate directed to a non-cell surface therapeutic target
PendingMDE20260166A1
Owner:MAINEHEALTH
siRNA targeting AGT gene expression and conjugate and use thereof
PendingMDE20260512A1
Owner:LEADERNA THERAPEUTICS LTD
User equipment configured for conditional handover with dual connectivity
PendingMDE20260228A1
Owner:NOKIA TECHNOLOGIES OY
Anti-factor XII / XIIa antibodies and uses thereof
PendingMDE20260413A1
Owner:REGENERON PHARMACEUTICALS INC
Process and catalysts for the production of ethylene and propylene from low-carbon syngas
PendingMDE20260385A1
Owner:GREYROCK TECH LLC
Crystals of 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives
PendingMDE20260605A1
Owner:TAIHO PHARMA CO LTD
Methods of treating a sleep disorder using a triple reuptake inhibitor
PendingMDE20260528A1
Owner:NOEMA PHARMA AG
Substituted piperidinediones for targeted protein degradation
PendingMDE20260429A1
Owner:MONTE ROSA THERAPEUTICS AG
Compounds and methods for reducing PLN expression
PendingMDE20260143A1
Owner:IONIS PHARMACEUTICALS INC
A structural photovoltaic (PV) panel and reinforced frame element adapted for modular construction and enclosures and PV devices formed therefrom
PendingMDE20260031A1
Owner:BRIGGS MAURICE
Therapeutic methods and compositions for treating movement disorders
PendingMDE20260211A1
Owner:VIMA THERAPEUTICS INC
Title of the invention: A plasma printing process to manufacture and produce battery electrodes and enhance current collectors
PendingMDE20260265A1
Owner:TEKRIWAL KRISHNAKANT
Combination of anti-CDH6 antibody-drug conjugate with VEGF inhibitor
PendingMDE20260090A1
Owner:DAIICHI SANKYO CO LTD
A method for determining the presence of native natural intelligence in a therapeutic or beneficial product
PendingMDE20260150A1
Owner:BIOS-THERAPY PHYSIOLOGICAL SYSTEMS FOR HEALTH SPA IT
Nutraceutical composition for use in the treatment of subjects over 50 with chronic fatigue
PendingMDE20260695A1
Owner:PHARMANUTRA SPA
Compounds and formulations useful as vaccine adjuvants
PendingMDE20260255A1
Owner:MERCK SHARP & DOHME LLC
Antisense oligomers for treatment of centronuclear myopathies
PendingMDE20260668A1
Owner:SAREPTA THERAPEUTICS INC +1
Methods of treating clear cell renal cell carcinoma with bispecific anti-PSMA x anti-CD28 antibodies
PendingMDE20260452A1
Owner:REGENERON PHARMACEUTICALS INC
Electronic module for a metered dose inhaler and metered dose inhaler assembly comprising the electronic module
PendingMDE20260426A1
Owner:CHIESI FARMACEUTICI SPA
Compositions and methods of using prkag2-targeting antibody-oligonucleotide conjugates
PendingMDE20260369A1
Owner:ATRIUM THERAPEUTICS INC
ABCB5-targeted stem cell reprogramming and anti-aging strategies
PendingMDE20260703A1
Owner:CHILDRENS MEDICAL CENT CORP +1
Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof
PendingMDE20260155A1
Owner:PFIZER INC
Humanized DNM2 mouse model generation, characterization and methods of use
PendingMDE20260665A1
Owner:SAREPTA THERAPEUTICS INC
Hydraulic walking system, control method for hydraulic walking system, and static hydraulic loader
PendingMDE20260519A1
Owner:SHANDONG LINGONG CONSTR MACHINERY CO LTD
Methods for treating obsessive compulsive related disorders, tic disorders and glutamate excitotoxicity related disorders
PendingMDE20260050A1
Owner:BIOHAVEN THERAPEUTICS LTD
Crystalline salt forms of N-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide and methods of use thereof
PendingMDE20260055A1
Owner:PRAXIS PRECISION MEDICINES INC
Bispecific PD-L1xCD28 antibodies and methods of use thereof
PendingMDE20260396A1
Owner:REGENERON PHARMACEUTICALS INC
Stable protein compositions of anti-PD1 antibody
PendingMDE20260009A1
Owner:SUN PHARMACEUTICAL INDUSTRIES LTD